Limitations of rapid myelin water quantification using 3D bSSFP

Object  

Imaging of the myelin water fraction (MWF) is conventionally performed using a multi-echo spin-echo sequence. This technique requires long acquisition times and therefore often suffers from a lack of volume coverage. In this work, the application of 3D balanced steady-state free precession (bSSFP) sequences to extract high-resolution myelin water maps is discussed.     

High glycolytic potential does not predict low ultimate pH in pork

Extent of postmortem pH decline influences meat quality development. To better understand physiological determination of ultimate pH (pH_u), we utilized female and castrated male pigs from a line whose selection index includes differentiated pH_u. All genotypes of AMP-activated protein kinase γ3 subunit (AMPKγ3) V199I site were present. The mutant 199II genotype increased pH_u, but only in castrated males. Genotype affected glycolytic potential (GP), but GP was weakly associated with pH_u. A subset of animals was selected based on low (− Gly) and high (+ Gly) residual glycogen content, and compared with AMPKγ3 200Q, which is associated with low pH_u. Both + Gly and 200Q muscle contained glycolytic substrate at 24 h; however, 200Q muscle generated low pH_u and greater lactate compared to + Gly. Additionally,− Gly and + Gly groups exhibited similar pH_u despite a large difference in GP. In conclusion, high GP does not appear to directly impact the extent of postmortem pH decline.     

Antinociceptive analogs of orphanin FQ/nociceptin(1-11)

The presence of pairs of basic amino acids within the sequence of orphanin FQ/nociceptin (OFQ/N) peptide, the endogenous ligand for the ORL1/KOR-3 receptor, has raised the possibility that processing might generate pharmacologically important truncated peptides, including OFQ/N(1-11). OFQ/N(1-11) is pharmacologically active in vivo with a potency comparable to OFQ/N. Several tyrosine-containing analogs of OFQ/N(1-11) have been synthesized and examined for antinociceptive activity. Like OFQ/N(1-11), [Tyr1]OFQ/N(1-11), [Tyr10]OFQ/N(1-11) and [IodoTyr10]OFQ/N(1-11) given supraspinally in mice were antinociceptive in the tailflick assay in mice. The tyrosine analogs showed similar potencies as OFQ/N(1-11) but longer durations of action. This response was readily reversed by the opioid antagonist naloxone despite poor affinities for these analogs at opioid receptors. Another compound, [Tyr11]OFQ/N(1-11) was highly epileptogenic, inducing naloxone-sensitive seizures in greater than 50% of the mice tested at doses comparable to those examined with the other analogs. These results indicate that it is possible to make analgesic OFQ/N(1-11) analogs. The activity of [IodoTyr10]OFQ/N(1-11) suggests that it may prove useful as a radioligand in exploring potential OFQ/N(1-11) binding sites.     

Characterization of the human SDHC gene encoding of the integral membrane proteins of succinate-quinone oxidoreductase in mitochondria

The neurological manifestations of multiple sclerosis (MS) have been considered to result from demyelination of axons with relative preservation of axonal integrity. This concept has been challenged recently by a landmark pathological study, published in the New England Journal of Medicine, which has demonstrated that axonal degeneration is also present. The authors of the study hypothesized that axonal degeneration is the pathological correlate of the irreversible neurological impairment in this disease. However, this hypothesis cannot be reconciled with the clinical results obtained with transcranial applications of AC pulsed electromagnetic fields (EMFs) of picotesla flux density which have shown rapid and sustained improvement of symptoms including normalization of evoked potential responses in patients with chronic progressive or secondary progressive MS without demyelinated areas first undergoing remyelination or transected axons undergoing regeneration. Biochemical studies have shown that MS patients are serotonergically depleted with the extent of cerebral depletion correlating with the degree of motor disability and a chronic progressive course. It is believed that progressive serotonergic neuronal atrophy with synaptic inactivation, not axonal degeneration, are the hallmarks of the disease and that administration of AC pulsed magnetic fields improves symptoms of MS partly through reactivation of serotonergic neurons and amplification of synaptic serotonergic transmission.     

Virtual prototyping for high density packaging systems

Very early in an electronic design cycle the physical buildup of a system, such as bonding method, substrate technology, and number of layers, needs to be chosen before any layout is performed. But when developing high density systems, a huge number of technology choices are available, each having impact on various aspects of the system performance. This paper describes virtual prototyping as a method for systematically analyzing and choosing the suitable buildups and selecting one of them in a cost-performance analysis for implementation and layout. Unlike former design advisors, our method analyzes several possibilities in parallel, allowing for a better design space exploration. The framework is implemented in the Java based tool JavaCAD, JavaCAD manages the different buildups and provides a size/layer count estimation for all first level interconnect/packages on various substrate technologies. It calculates the component footprints, analyzes the routing with as few data as available and allows cost estimation of all feasible buildups. The benefits of our approach are illustrated in the design of a 9:4 satellite switch operating at 2.4 GHz     

The laboratory diagnosis of spring-summer infections in Yekaterinburg in the epidemic season for tick-borne encephalitis

The authors propose a comprehensive approach to laboratory diagnosis of seasonal transmissible infections, based on modern methods permitting etiological deciphering of disease. A universal diagnostic algorithm notably accelerated the laboratory diagnosis due to cutting the period between collection of material from a patient and consecutive screening for antibodies to agents of tick-borne encephalitis, Lyme disease, and California encephalitis.